BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $96 at Morgan Stanley
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $57.18 -2.16%
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $96.00 (from $90.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- BioMarin shares five-year Pompe disease drug data at muscle congress
- JPMorgan Upgrades Sandfire Resources NL (SFR:AU) (SNDFY) to Overweight
- Macquarie Upgrades Merdeka Copper Gold Tbk PT (MDKA:IJ) to Outperform
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
